[DOI] [PubMed] [Google Scholar] 103.Zhao Y., Ye X., Xiong Z., Ihsan A., Ares I., Martnez M., Lopez-Torres B., Martnez-Larraaga M.R., Anadn A., Wang X., et al
According to the results of the Dutch test, it can be a lifesaver for women that have gone through menopause, no matter how far out of menopause they are
I = 99.2%, = 0.11), implying that the between-study variance in true effect sizes far exceeded what could be attributed to random error
Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer
Market Report Coverage and Key Metrics Market Dynamics Drivers Shift to Oral Formulations The shift to oral formulations is a main driver of the GLP-1 market because it directly removes patient barriers, simplifies daily routines, needle anxiety, and eliminates complex cold chain logistics
Suchitra MM, Ashalatha VL, Sailaja E, Rao AM, Reddy VS, Bitla AR, et al